B-Cell-directed therapies: A new era in multiple sclerosis treatment
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central
nervous system (CNS) that often progresses to severe disability. Previous studies have …
nervous system (CNS) that often progresses to severe disability. Previous studies have …
B-Cell-Directed Therapies: A New Era in Multiple Sclerosis Treatment
P Kanatas, I Stouras, L Stefanis… - … Canadian journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central
nervous system (CNS) that often progresses to severe disability. Previous studies have …
nervous system (CNS) that often progresses to severe disability. Previous studies have …
[PDF][PDF] B-Cell-Directed Therapies: A New Era in Multiple Sclerosis Treatment
P Kanatas, I Stouras, L Stefanis… - The Canadian Journal …, 2022 - researchgate.net
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central
nervous system (CNS) that often progresses to severe disability. Previous studies have …
nervous system (CNS) that often progresses to severe disability. Previous studies have …
B-Cell-Directed Therapies: A New Era in Multiple Sclerosis Treatment.
P Kanatas, I Stouras, L Stefanis… - The Canadian Journal of …, 2022 - europepmc.org
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central
nervous system (CNS) that often progresses to severe disability. Previous studies have …
nervous system (CNS) that often progresses to severe disability. Previous studies have …